Are you Dr. Ganesan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 2 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1400 Holcombe Blvd
Inv Cancer Therapeutics, Md Anderson Cancer Center
Houston, TX 77030Phone+1 713-563-8965Fax+1 713-792-5553
Clinical Trials
- Use of Interim PET Scan to Modify Therapy in Advanced Hodgkin's Lymphoma in Order to Improve Outcomes Start of enrollment: 2011 Jan 01
Publications & Presentations
PubMed
- 150 citationsNonadherence to Imatinib adversely affects event free survival in chronic phase chronic myeloid leukemiaPrasanth Ganesan, Tenali Gnana Sagar, Biswajit Dubashi, Rejiv Rajendranath, Krishnarathinam Kannan
American Journal of Hematology. 2011-06-01 - 58 citationsEvaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies.Rami N. Al-Rohil, Ashley J Tarasen, J. Andrew Carlson, Kai Wang, Adrienne Johnson
Cancer. 2016-01-15 - 3 citationsA modified olanzapine-based anti-emetic regimen for the control of nausea and vomiting in patients receiving weekly cisplatin.Nikita Mehra, Vasanth Christopher, Manikandan Dhanushkodi, Venkatraman Radhakrishnan, Trivadi S. Ganesan
International Journal of Clinical Pharmacy. 2020-03-09
Press Mentions
Prasanth Ganesan, MD, DM, on Olanzapine for Whetting the Appetite During ChemotherapyJune 28th, 2023
